By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sandoz, Inc. 

506 Carnegie Center Drive, Suite 400

Princeton  New Jersey  08540  U.S.A.
Phone: 609-627-8500 Fax: 609-627-8683




Company News
Sandoz Proposed Biosimilars Rituximab And Etanercept Recommended For Approval In Europe* 4/24/2017 11:43:48 AM
New Data Demonstrate Sandoz Proposed Biosimilar Adalimumab Has Equivalent Efficacy To Reference Medicine 3/6/2017 6:54:30 AM
Sandoz Launches Generic Version Of Emend Capsules 1/4/2017 10:16:00 AM
Sandoz To Donate Up To USD 10 Million Of High-Quality Generic Medicines Annually To Americares To Increase Access To Medicines 11/22/2016 9:19:55 AM
Former Sandoz CEO Joins Supervisory Board Of LEUKOCARE 7/15/2016 6:54:12 AM
Ex Novartis AG (NVS)-Sandoz CEO to Lead AAT Research’s Global Expansion 4/7/2016 6:17:51 AM
Novartis AG (NVS)'s Sandoz to Consolidate Two N.Y. Manufacturing Sites, No Job Losses Expected 3/10/2016 6:15:47 AM
United Therapeutics (UTHR) Announces Settlement Of Patent Litigation With Sandoz 9/30/2015 6:59:41 AM
Novartis AG (NVS)’s Sandoz Shuttered Three Plants, Lays Off 720 7/24/2015 6:39:53 AM
Novartis AG (NVS) Release: FDA Approves First Biosimilar Zarxi (Filgrastim-Sndz) From Sandoz 3/6/2015 7:46:53 AM